The US Food and Drug Administration (FDA) approved Vertex Pharmaceuticals' drug, Journavx, for short-term pain relief ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

Journavx is designed to eliminate the risks of addiction and overdose associated with medications like Vicodin and OxyContin.

A new type of non-opioid painkiller, aimed at treating short-term pain in adults, has been approved by the US Food and Drug Administration (FDA). The drug suzetrigine, known by its brand name Journavx ...

Biodegradable materials, including polymers, degrade naturally, reducing pollution and offering eco-friendly solutions for packaging and medical applications.

When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts ...

Swiss pharmaceutical giant Novartis (NVS) on Friday reported forecast-beating quarterly sales as its clutch of heart failure to breast cancer ...

HIV has become a more manageable condition in recent years, but a full cure remains elusive. Now, scientists have found ...

Kennedy has tried to recast his anti-vaccine extremism as an honest effort to illuminate what he claims is unsettled science (it’s not). He insists he’s not trying to take away anyone’s shots; he’s ...

On Thursday, in a major step forward in pain management, the U.S. Food and Drug Administration has approved a new nonopioid ...